A Case of Complete Response to Letrozol Treatment in a Postmenopausal Woman With Breast Cancer Who has Progressed After Multiple Lines of Chemotherapy

Approximately 60% of all breast cancers are endocrine dependent. Postmenopausal patients who have positive hormone receptor status are eligible for aromatase inhibitor treatment. Letrozole is a potent, selective, non-steroidal, third-generation aromatase inhibitor which reduces oestrogen biosynthesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tural, Deniz, Akar, Emre, Sager, Sait, Yildiz, Ozcan, Ozguroglu, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649921/
https://www.ncbi.nlm.nih.gov/pubmed/29147332
http://dx.doi.org/10.4021/wjon628w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649921/
https://www.ncbi.nlm.nih.gov/pubmed/29147332
http://dx.doi.org/10.4021/wjon628w

Ejemplares similares